{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:36:29Z","timestamp":1762079789406,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.micpath.2021.105073","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T13:33:57Z","timestamp":1624628037000},"page":"105073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The role of cytotoxic T-Lymphocyte antigen-4+49A\/G gene polymorphism in cutaneous leishmaniasis"],"prefix":"10.1016","volume":"158","author":[{"given":"Mohammed J.S.","family":"Al-Ghabban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagham Y.","family":"Al-Bayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qasim S.","family":"Al-Mayah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3591-9434","authenticated-orcid":false,"given":"Hisham Y.","family":"Al-Matubsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.105073_bib1","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2021.105073_bib2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.12688\/f1000research.11120.1","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"a review. F1000Res"},{"key":"10.1016\/j.micpath.2021.105073_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.meegid.2016.03.031","article-title":"Genetic diversity of Leishmania tropica strains isolated from clinical forms of cutaneous leishmaniasis in rural districts of Herat province, Western Afghanistan, based on ITS1-rDNA","volume":"41","author":"Fakhar","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2021.105073_bib4","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1016\/S1995-7645(14)60227-3","article-title":"Diversity and incrimination of sandflies (Psychodidae: phlebotominae) captured in city and suburbs of Hamadan, Hamadan province, west of Iran","volume":"7","author":"Salehzadeh","year":"2014","journal-title":"Asian Pacific J Trop Med"},{"key":"10.1016\/j.micpath.2021.105073_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003208","article-title":"Leishmaniasis in the middle East: incidence and epidemiology","volume":"8","author":"Salam","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2021.105073_bib6","first-page":"255","article-title":"The distribution of cutaneous leishmaniasis in Iraq: demographic and climate aspects","volume":"11","author":"Al-Warid","year":"2017","journal-title":"Asian Biomed."},{"key":"10.1016\/j.micpath.2021.105073_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(05)59001-8","article-title":"Genes and susceptibility to leishmaniasis","volume":"59","author":"Handman","year":"2005","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.micpath.2021.105073_bib8","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/jid.2013.4","article-title":"CD8+ granzyme B+\u2013mediated tissue injury vs. CD4+ IFN\u03b3+\u2013mediated parasite killing in human cutaneous leishmaniasis","volume":"133","author":"Santos","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.micpath.2021.105073_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immuonotherapy","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2021.105073_bib10","first-page":"235","article-title":"Investigation of CTLA-4 and CD28 gene polymorphisms in patients with diabetes mellitus type 2 using PCR-RFLP in a Turkish population","volume":"59","author":"Uzer","year":"2010","journal-title":"W. Indian Med. J."},{"key":"10.1016\/j.micpath.2021.105073_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/gtmb.2016.0335","article-title":"CTLA-4+ 49 G\/A polymorphism confers autoimmune disease risk: an updated meta-analysis","volume":"21","author":"Wang","year":"2017","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.micpath.2021.105073_bib12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4103\/0973-1482.191065","article-title":"Association of cytotoxic T-lymphocyte antigen 4 rs231775 gene polymorphism with colorectal cancer risk","volume":"14","author":"Zhang","year":"2018","journal-title":"J. Canc. Res. Therapeut."},{"key":"10.1016\/j.micpath.2021.105073_bib13","doi-asserted-by":"crossref","first-page":"e12143","DOI":"10.5812\/jjm.12143","article-title":"The cytotoxic T lymphocyte antigen-4 +49A\/G single nucleotide polymorphism association with visceral leishmaniasis","volume":"7","author":"Hajilooi","year":"2014","journal-title":"Jundishapur J. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2021.105073_bib14","first-page":"240","article-title":"Cytotoxic T-lymphocyte associated antigen-4 (+49A\/G) gene polymorphism as a protective factor against toxoplasmosis","volume":"14","author":"Allami","year":"2017","journal-title":"Med J Babylon"},{"key":"10.1016\/j.micpath.2021.105073_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.humimm.2009.03.016","article-title":"Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases","volume":"70","author":"Fernandez-Mestre","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.micpath.2021.105073_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ni884","article-title":"CTLA-4 regulates the requirement for cytokine induced signals in Th2 lineage commitment","volume":"4","author":"Bour-Jordan","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.micpath.2021.105073_bib17","first-page":"169","article-title":"Inhibition of T cell activation by CTLA-4: truths and red herrings","volume":"1","author":"Baroja","year":"2000","journal-title":"Mod Asp Immunobiol"},{"key":"10.1016\/j.micpath.2021.105073_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ajh.10278","article-title":"CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders","volume":"72","author":"Pavkovic","year":"2003","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.micpath.2021.105073_bib19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.4049\/jimmunol.175.2.996","article-title":"Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation","volume":"175","author":"Darlington","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2021.105073_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004426","article-title":"Cutaneous leishmaniasis: an overlooked etiology of midfacial destructive lesions","volume":"10","author":"Alam","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2021.105073_bib21","first-page":"155","article-title":"Mechanisms of immune evasion in leishmaniasis","volume":"vol. 82","author":"Gupta","year":"2013"},{"key":"10.1016\/j.micpath.2021.105073_bib22","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/eji.201242529","article-title":"The soluble isoform of CTLA-4 as regulator of T-cell responses","volume":"43","author":"Ward","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2021.105073_bib23","first-page":"336","article-title":"The soluble CTLA-4 receptor: a new marker in autoimmunes diseases","volume":"53","author":"Pawlak","year":"2005","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.micpath.2021.105073_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044654","article-title":"A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukemia and correlates with CD1d+ expression","volume":"7","author":"Simone","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.105073_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1081\/JAS-51331","article-title":"Soluble CTLA-4 in sera of patients with bronchial asthma","volume":"42","author":"Shi","year":"2005","journal-title":"J. Asthma"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021003454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021003454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:37:49Z","timestamp":1760110669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021003454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":25,"alternative-id":["S0882401021003454"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105073","relation":{},"ISSN":["0882-4010"],"issn-type":[{"type":"print","value":"0882-4010"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of cytotoxic T-Lymphocyte antigen-4+49A\/G gene polymorphism in cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105073"}}